Article and Video CATEGORIES
Denise has over 30 years of varying experience in the healthcare arena. In August 2009 she joined The Global Resource for Advancing Cancer Education as one of its first employees. She has grown with the organization and now oversees the operational movement of programs, efficiency, and effectiveness within the organization, as well as the daily processes and functions.
Chaundra’s story is shared as part of the Patient Perspectives - Clinical Trials Experiences Storytelling Program
This program aims to give those diagnosed with cancer a voice to share their experiences participating in clinical trials and help others understand the importance of participating in clinical trials.
"Saying Yes" is Chaundra's story. Diagnosed in 2016 with Stage lV Intrahepatic Cholangiocarcinoma, she has not stopped living. She has maintained a full-time job and currently serves as the Champaign Regional Health Officer for the Illinois Department of Public Health. Chaundra was elected to the Urbana City Council in 2021, serves on the Planned Parenthood Illinois Action Board of Directors, and is the president of the Urbana-Champaign chapter of Sigma Gamma Rho Sorority, Inc.
Chandra's story is one of living, and saying YES to life through her cancer diagnosis, treatments, and clinical trials.
To download a copy of Saying Yes, please follow this link:
https://drive.google.com/file/d/1BH3tvFqAuBrR2aejYRKGp9QtppjpNom0/view?…
We recommend viewing this video on YouTube for a better viewing experience! Please visit
https://youtu.be/Vu-dFwScrHU?si=tDuS0KjWmluqw7sz
A huge thanks to our sponsors! #exelixis #lilly #merck #blueprintmedicines
Please feel free to offer comments and raise questions in our
discussion forums.
Related Content
Forum Discussions
Hi elysianfields and welcome to Grace. I'm sorry to hear about your father's progression.
Unfortunately, lepto remains a difficult area to treat. Recently FDA approved the combo Lazertinib and Amivantamab...
Hello Janine, thank you for your reply.
Do you happen to know whether it's common practice or if it's worth taking lazertinib without amivantamab? From all the articles I've come across...
Hi elysianfields,
That's not a question we can answer. It depends on the individual's health. I've linked the study comparing intravenous vs. IV infusions of the doublet lazertinib and amivantamab...
Hello Linda, my name is Alexandra Beneke, I'm the Outreach Manager for GRACE. Your willingness to share your experiences and knowledge with the cancer community is truly inspiring. Your dedication to...
Recent Comments
That's…